Nonlinear mixed-effects model for the dissolution assays of drugs

Journal of Controlled Release

Volumn 94, Issue 2-3, 2004, Pages 381-389

  Frutos, G ^a   Ruiz De Villa, M C ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Inert matrix tablets; Longitudinal data; Mathematical model; Pharmaceutical statistics; Release profiles

Indexed keywords

ASSAYS; CONTROLLED DRUG DELIVERY; DISSOLUTION; POLYMERS;

POLYMERIC MATRIX TABLETS; POPULATION MODELS;

DRUG PRODUCTS;

METOCLOPRAMIDE; POLYAMIDE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; MATHEMATICAL MODEL; MATRIX TABLET; PRIORITY JOURNAL; TABLET FORMULATION;

EID: 1642482827     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2003.10.017     Document Type: Article

References (28)

1. Chien Y.W. Chien Y.W. Novel Drug Delivery Systems. 2nd ed. 1997;1-42 Marcel Dekker, New York.
2. Pabón C.V., Frutos P., Lastres J.L., Frutos G. In vitro study of mixed controlled release matrix tablets containing HMPC and polyamide 12. Drug Dev. Ind. Pharm. 18:1994;2509-2518.
3. Pabón C.V., Frutos P., Lastres J.L., Frutos G. Matrix tablets containing HPMC and polyamide 12: comparison of dissolution data using Gompertz function. Drug Dev. Ind. Pharm. 18:1992;2163-2171.
4. Extended Release Dosage Forms: Development, Evaluation and Application of In Vitro/In Vivo Correlations. 1997;The Drug Information Branch, HFD-210, Fishers Lane, Rockville, MD 20857.
5. Frutos P., Pavon C.V., Lastres J.L., Frutos G. In vitro release of metoclopramide from hydrophobic matrix tablets. Influence of hydrodynamic conditions on kinetics release parameters. Chem. Pharm. Bull. 49:2001;1267-1271.
6. Rodriguez A., Frutos P., Frutos G. Granules de polyamide inerte utilises comme matrice libération prolongée. Stp Pharma. 6:1990;574-581.
7. Adams E., De Measschalck R., De Spiegeleer B., Vander Heyden Y., Smeyers-Verbeke J., Massar D.L. Evaluation of dissolution profiles using principal component analysis. Int. J. Pharm. 212:2001;41-53.
8. Polli J.E., Rekhi G.S., Shah V.P. Methods to compare dissolution profiles. Drug Inf. J. 30:1996;1113-1120.
9. Yuksel N., Kanik A.E., Baykara T. Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and -independent methods. Int. J. Pharm. 20:2000;57-67.
10. Costa P., Sousa Lobo J.M. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 13:2001;123-133.
11. Peppas N.A. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. 60:1985;110-111.
12. Bartoszynski R., Powers J.D., Herderick E.E., Pultz J.A. Statistical comparison of dissolution curves. Pharmacol. Res. 43:2001;369-387.
13. Sheiner L.B., Beal S.L. Evaluation of methods for estimating pharmacokinetics parameters: I. Michaelis-Menten model; routine clinical pharmacokinetic data. J. Pharmacokinet. Biopharm. 8:1980;553-571.
14. Karlsson M.O., Port R.E., Retain M.R., Sheiner L.B. A population model for the leukopenic effect of etoposide. Clin. Pharmacol. Ther. 57:1995;325-334.
15. Davidian M., Giltinan D.M. Nonlinear Models for Repeated Measurement Data. 1995;237-272 Chapman & Hall, Florida, USA.
16. European Pharmacopoeia, 2nd ed., 2000.
17. S-PLUS, MathSoth, Data Analysis Products Division, Seattle, WA, 2000.
18. Lindstrom M.J., Bates D.M. Nonlinear mixed-effects models for repeated measures data. Biometrics. 46:1990;673-687.
19. Pinheiro J.C., Bates D.M. Mixed-Effects Models in S and S-PLUS. 2000;305-309 Springer, New York, USA.
20. Wolfinger R.D., Tobias R.D. Joint estimation of location, dispersion, and random effects in robust design. Technometrics. 40:1998;62-71.
21. Bardsley W.G., McGinlay P.B., Wright A.J. The F test for model discrimination with exponential function. Biometrika. 73:1986;501-508.
22. Frutos P., Rodríguez A., Frutos G., Martín P.J. Mathematical approach to effects of new excipient, Orgasol, in the study of released-controlled tablets. Pharm. Acta Helv. 66:1991;339-341.
23. Cnaan A., Laird N.M., Slasor P. Using the general linear model to analyse unbalanced repeated measures and longitudinal data. Stat. Med. 16:1997;2349-2380.
24. Zimmerman D.L., Núñez-Antón V. Parametric modeling of growth curve data: an overview. Test. 10:2001;1-72.
25. Vonesh E.F., Carter R.L. Mixed-effects nonlinear regression for unbalanced repeated measures. Biometrics. 48:1992;1-18.
26. Sheiner L.B., Beal S.L. Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten: routine clinical pharmacokinetics data. J. Pharmacokinet. Biopharm. 8:1980;553-571.
27. Davidian M., Giltinan D.M. Nonlinear Models for Repeated Measurement Data. 1995;101-107 Chapman & Hall, Florida, USA.
28. Pinheiro J.C., Bates D.M. Mixed-Effects Models in S and S-PLUS. 2000;351 Springer, New York, USA.